US 10548899
Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity
granted A61KA61K31/517A61K31/53
Quick answer
US patent 10548899 (Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity) held by Takeda Pharmaceutical Company Limited expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/517, A61K31/53, A61P, A61P25/04